Literature DB >> 7529008

Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels.

C H van de Lest1, E M Versteeg, J H Veerkamp, T H van Kuppevelt.   

Abstract

A rapid, sensitive, and nonradioactive method has been developed for the quantification and characterization of glycosaminoglycans. The method is based on the separation of different types of glycosaminoglycans in agarose gel and subsequent fixation and staining with the cationic dye azure A, followed by silver enhancement. Densitometric analysis of the silver deposition gives a linear response between 1 and 20 ng for chondroitin and dermatan sulfate and between 2 and 40 ng for heparan sulfate. The detection limit is about 250 pg. The staining procedure was applied for the quantification and characterization of glycosaminoglycans in human serum, urine, and lung and in mouse kidney glomeruli. It requires only 10 microliters serum, 2 microliters urine, and only a single cryosection in case of tissue. The method is at least as sensitive as staining with radioactive markers and about 200 times more sensitive than conventional glycosaminoglycan-staining methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529008     DOI: 10.1006/abio.1994.1425

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  18 in total

1.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

2.  Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice.

Authors:  F Jason Duncan; Bartholomew J Naughton; Kimberly Zaraspe; Darren A Murrey; Aaron S Meadows; Kelly Reed Clark; David E Newsom; Peter White; Haiyan Fu; Douglas M McCarty
Journal:  Mol Ther       Date:  2015-01-16       Impact factor: 11.454

3.  Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery.

Authors:  Haiyan Fu; Julianne Dirosario; Smruti Killedar; Kimberly Zaraspe; Douglas M McCarty
Journal:  Mol Ther       Date:  2011-03-08       Impact factor: 11.454

4.  IgG-cleavage protein allows therapeutic AAV gene delivery in passively immunized MPS IIIA mice.

Authors:  Tierra A Bobo; Preston N Samowitz; Michael I Robinson; Laura I Montes; Lawrence J Forsberg; Richard Feng; Nathan I Nicely; Haiyan Fu
Journal:  Gene Ther       Date:  2022-10-17       Impact factor: 4.184

5.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

6.  Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas.

Authors:  Gerdy B Ten Dam; Shuhei Yamada; Fumi Kobayashi; Anurag Purushothaman; Els M A van de Westerlo; Johan Bulten; Anders Malmström; Kazuyuki Sugahara; Leon F Massuger; Toin H van Kuppevelt
Journal:  Histochem Cell Biol       Date:  2009-04-10       Impact factor: 4.304

7.  Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.

Authors:  M C van Bruggen; K Kramers; M N Hylkema; J van den Born; M A Bakker; K J Assmann; R J Smeenk; J H Berden
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

8.  Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.

Authors:  Douglas M McCarty; Julianne DiRosario; Kadra Gulaid; Smruti Killedar; Arie Oosterhof; Toin H van Kuppevelt; Paul T Martin; Haiyan Fu
Journal:  Metab Brain Dis       Date:  2011-01-12       Impact factor: 3.584

9.  Characterization of anticoagulant heparinoids by immunoprofiling.

Authors:  Tessa J Wijnhoven; Els M van de Westerlo; Nicole C Smits; Joost F Lensen; Angelique L Rops; Johan van der Vlag; Jo H Berden; Lambert P van den Heuvel; Toin H van Kuppevelt
Journal:  Glycoconj J       Date:  2007-10-02       Impact factor: 2.916

10.  Naturally occurring and stress induced tubular structures from mammalian cells, a survival mechanism.

Authors:  Yonnie Wu; Richard C Laughlin; David C Henry; Darryl E Krueger; JoAn S Hudson; Cheng-Yi Kuan; Jian He; Jason Reppert; Jeffrey P Tomkins
Journal:  BMC Cell Biol       Date:  2007-08-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.